VIGL logo

Vigil Neuroscience (VIGL) EBITDA

Annual EBITDA

-$88.47 M
-$19.66 M-28.57%

December 31, 2023


Summary


Performance

VIGL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIGLprofitabilitymetrics:

Quarterly EBITDA

-$20.56 M
+$1.80 M+8.06%

September 30, 2024


Summary


Performance

VIGL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIGLprofitabilitymetrics:

TTM EBITDA

-$87.97 M
+$1.65 M+1.84%

September 30, 2024


Summary


Performance

VIGL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIGLprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

VIGL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.6%+7.4%-5.3%
3 y3 years-+7.4%-5.3%
5 y5 years-+7.4%-5.3%

VIGL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-108.7%at low-58.6%+13.4%-107.6%+1.8%
5 y5-year-108.7%at low-406.6%+13.4%-279.9%+1.8%
alltimeall time-108.7%at low-406.6%+13.4%-279.9%+1.8%

Vigil Neuroscience EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$20.56 M(-8.1%)
-$87.97 M(-1.8%)
Jun 2024
-
-$22.36 M(+5.0%)
-$89.62 M(+0.6%)
Mar 2024
-
-$21.30 M(-10.3%)
-$89.06 M(+0.7%)
Dec 2023
-$88.47 M(+28.6%)
-$23.74 M(+6.9%)
-$88.47 M(+5.9%)
Sep 2023
-
-$22.21 M(+1.9%)
-$83.58 M(+5.8%)
Jun 2023
-
-$21.80 M(+5.3%)
-$78.98 M(+6.4%)
Mar 2023
-
-$20.71 M(+9.9%)
-$74.20 M(+7.8%)
Dec 2022
-$68.81 M
-$18.85 M(+7.0%)
-$68.81 M(+9.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$17.62 M(+3.5%)
-$62.92 M(+12.3%)
Jun 2022
-
-$17.02 M(+11.2%)
-$56.03 M(+12.6%)
Mar 2022
-
-$15.31 M(+18.1%)
-$49.78 M(+17.5%)
Dec 2021
-$42.38 M
-$12.96 M(+20.8%)
-$42.38 M(+26.6%)
Sep 2021
-
-$10.73 M(-0.5%)
-$33.48 M(-27.1%)
Jun 2021
-
-$10.78 M(+36.1%)
-$45.91 M(+30.7%)
Mar 2021
-
-$7.92 M(+95.1%)
-$35.13 M(+29.1%)
Dec 2020
-
-$4.06 M(-82.5%)
-$27.21 M(+17.5%)
Sep 2020
-
-$23.16 M
-$23.16 M

FAQ

  • What is Vigil Neuroscience annual EBITDA?
  • What is the all time high annual EBITDA for Vigil Neuroscience?
  • What is Vigil Neuroscience annual EBITDA year-on-year change?
  • What is Vigil Neuroscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Vigil Neuroscience?
  • What is Vigil Neuroscience quarterly EBITDA year-on-year change?
  • What is Vigil Neuroscience TTM EBITDA?
  • What is the all time high TTM EBITDA for Vigil Neuroscience?
  • What is Vigil Neuroscience TTM EBITDA year-on-year change?

What is Vigil Neuroscience annual EBITDA?

The current annual EBITDA of VIGL is -$88.47 M

What is the all time high annual EBITDA for Vigil Neuroscience?

Vigil Neuroscience all-time high annual EBITDA is -$42.38 M

What is Vigil Neuroscience annual EBITDA year-on-year change?

Over the past year, VIGL annual EBITDA has changed by -$19.66 M (-28.57%)

What is Vigil Neuroscience quarterly EBITDA?

The current quarterly EBITDA of VIGL is -$20.56 M

What is the all time high quarterly EBITDA for Vigil Neuroscience?

Vigil Neuroscience all-time high quarterly EBITDA is -$4.06 M

What is Vigil Neuroscience quarterly EBITDA year-on-year change?

Over the past year, VIGL quarterly EBITDA has changed by +$1.65 M (+7.42%)

What is Vigil Neuroscience TTM EBITDA?

The current TTM EBITDA of VIGL is -$87.97 M

What is the all time high TTM EBITDA for Vigil Neuroscience?

Vigil Neuroscience all-time high TTM EBITDA is -$23.16 M

What is Vigil Neuroscience TTM EBITDA year-on-year change?

Over the past year, VIGL TTM EBITDA has changed by -$4.40 M (-5.26%)